Drug profile · INN
glecaprevir + pibrentasvir
MAVIRET
glecaprevir + pibrentasvir (MAVIRET) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.
TGA: approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — glecaprevir + pibrentasvir
- Class
- —
- Route
- —
- Patents
- 1
- Programs
- 1
- Data quality
- 0.81
Quick answer
glecaprevir + pibrentasvir (MAVIRET) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is glecaprevir + pibrentasvir?
glecaprevir + pibrentasvir (MAVIRET) is an FDA-listed pharmaceutical active ingredient. Associated with AbbVie.
What is the brand name for glecaprevir + pibrentasvir?
MAVIRET is a marketed brand name for glecaprevir + pibrentasvir. Check FDA Drugs@FDA for the current US label holder and prescribing information.